期刊论文详细信息
BMC Medicine
Verbal autopsy as a tool for identifying children dying of sickle cell disease: a validation study conducted in Kilifi district, Kenya
Thomas N Williams4  Peter Byass1  Sailoki Kapesa3  Alex Macharia3  Gideon Nyutu3  Patrick Kosgei3  Alex Makazi3  George Mochamah3  Vysaul Nyirongo5  Evasius Bauni2  Carolyne Ndila2 
[1] WHO Collaborating Centre for Verbal Autopsy, Umeå University, 90187 Umeå, Sweden;INDEPTH Network of Demographic Surveillance Sites, Accra, Ghana;Kenya Medical Research Institute (KEMRI)/Wellcome Trust Programme, Centre for Geographic Medicine Research-Coast, P.O Box 230, Kilifi, Kenya;Department of Medicine, Imperial College, London W21NY, UK;United Nation Statistics Division, New York, USA
关键词: Kenya;    Child mortality;    Agreement coefficient;    Verbal autopsy;    Sickle cell disease;   
Others  :  854912
DOI  :  10.1186/1741-7015-12-65
 received in 2014-01-17, accepted in 2014-03-31,  发布年份 2014
PDF
【 摘 要 】

Background

Sickle cell disease (SCD) is common in many parts of sub-Saharan Africa (SSA), where it is associated with high early mortality. In the absence of newborn screening, most deaths among children with SCD go unrecognized and unrecorded. As a result, SCD does not receive the attention it deserves as a leading cause of death among children in SSA. In the current study, we explored the potential utility of verbal autopsy (VA) as a tool for attributing underlying cause of death (COD) in children to SCD.

Methods

We used the 2007 WHO Sample Vital Registration with Verbal Autopsy (SAVVY) VA tool to determine COD among child residents of the Kilifi Health and Demographic Surveillance System (KHDSS), Kenya, who died between January 2008 and April 2011. VAs were coded both by physician review (physician coded verbal autopsy, PCVA) using COD categories based on the WHO International Classification of Diseases 10th Edition (ICD-10) and by using the InterVA-4 probabilistic model after extracting data according to the 2012 WHO VA standard. Both of these methods were validated against one of two gold standards: hospital ICD-10 physician-assigned COD for children who died in Kilifi District Hospital (KDH) and, where available, laboratory confirmed SCD status for those who died in the community.

Results

Overall, 6% and 5% of deaths were attributed to SCD on the basis of PCVA and the InterVA-4 model, respectively. Of the total deaths, 22% occurred in hospital, where the agreement coefficient (AC1) for SCD between PCVA and hospital physician diagnosis was 95.5%, and agreement between InterVA-4 and hospital physician diagnosis was 96.9%. Confirmatory laboratory evidence of SCD status was available for 15% of deaths, in which the AC1 against PCVA was 87.5%.

Conclusions

Other recent studies and provisional data from this study, outlining the importance of SCD as a cause of death in children in many parts of the developing world, contributed to the inclusion of specific SCD questions in the 2012 version of the WHO VA instruments, and a specific code for SCD has now been included in the WHO and InterVA-4 COD listings. With these modifications, VA may provide a useful approach to quantifying the contribution of SCD to childhood mortality in rural African communities. Further studies will be needed to evaluate the generalizability of our findings beyond our local context.

【 授权许可】

   
2014 Ndila et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140722022157949.pdf 1079KB PDF download
70KB Image download
58KB Image download
61KB Image download
【 图 表 】

【 参考文献 】
  • [1]Rees DC, Williams TN, Gladwin MT: Sickle-cell disease. Lancet 2010, 376:2018-2031.
  • [2]Perutz MF, Rosa J, Schechter A: Therapeutic agents for sickle cell disease. Nature 1978, 275:369-370.
  • [3]Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN, Weatherall DJ, Hay SI: Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet 2013, 381:142-151.
  • [4]Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN: Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med 2011, 41:S398-S405.
  • [5]Modell B, Darlison M: Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008, 86:480-487.
  • [6]Scott JA, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, Molyneux CS, Kombe F, Tsofa B, Marsh K, Peshu N, Williams TN: Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol 2012, 41:650-657.
  • [7]Komba AN, Makani J, Sadarangani M, Ajala-Agbo T, Berkley JA, Newton CR, Marsh K, Williams TN: Malaria as a cause of morbidity and mortality in children with homozygous sickle cell disease on the coast of Kenya. Clin Infect Dis 2009, 49:216-222.
  • [8]Bauni E, Ndila C, Mochamah G, Nyutu G, Matata L, Ondieki C, Mambo B, Mutinda M, Tsofa B, Maitha E, Etyang A, Williams TN: Validating physician-certified verbal autopsy and probabilistic modeling (InterVA) approaches to verbal autopsy interpretation using hospital causes of adult deaths. Popul Health Metr 2011, 9:49. BioMed Central Full Text
  • [9]World Health O: International Statistical Classification of Diseases and Related Health Problems: ICD-10. Geneva: WHO; 1993.
  • [10]Byass P, Chandramohan D, Clark SJ, D'Ambruoso L, Fottrell E, Graham WJ, Herbst AJ, Hodgson A, Hounton S, Kahn K, Krishnan A, Leitao J, Odhiambo F, Sankoh OA, Tollman SM: Strengthening standardised interpretation of verbal autopsy data: the new InterVA-4 tool. Glob Health Action 2012, 5:1-8.
  • [11]Ascertaining and attributing causes of death [http://www.who.int/healthinfo/statistics/verbalautopsystandards/en/ webcite]
  • [12]Ojwang PJ, Ogada T, Beris P, Hattori Y, Lanclos KD, Kutlar A, Kutlar F, Huisman TH: Haplotypes and alpha globin gene analyses in sickle cell anaemia patients from Kenya. Br J Haematol 1987, 65:211-215.
  • [13]Sadarangani M, Makani J, Komba AN, Ajala-Agbo T, Newton CR, Marsh K, Williams TN: An observational study of children with sickle cell disease in Kilifi, Kenya. Br J Haematol 2009, 146:675-682.
  • [14]Scott JA, Berkley JA, Mwangi I, Ochola L, Uyoga S, Macharia A, Ndila C, Lowe BS, Mwarumba S, Bauni E, Marsh K, Williams TN: Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case–control study and a longitudinal study. Lancet 2011, 378:1316-1323.
  • [15]Gwet KL: Computing inter-rater reliability and its variance in the presence of high agreement. Br J Math Stat Psychol 2008, 61:29-48.
  • [16]Gwet KL: Handbook of Inter-Rater Reliability. 2nd edition. Gaithersburg, USA: Advanced Analytics LLC;
  • [17]The Comprehensive R Archive Network [http://cran.r-project.org/ webcite]
  • [18]Makani J, Williams TN, Marsh K: Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol 2007, 101:3-14.
  • [19]Williams TN, Uyoga S, Macharia A, Ndila C, McAuley CF, Opi DH, Mwarumba S, Makani J, Komba A, Ndiritu MN, Sharif SK, Marsh K, Berkley JA, Scott JAG: Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control study. Lancet 2009, 374:1364-1370.
  • [20]McAuley CF, Webb C, Makani J, Macharia A, Uyoga S, Opi DH, Ndila C, Ngatia A, Scott JA, Marsh K, Williams TN: High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood 2010, 116:1663-1668.
  • [21]Makani J, Komba AN, Cox SE, Oruo J, Mwamtemi K, Kitundu J, Magesa P, Rwezaula S, Meda E, Mgaya J, Pallangyo K, Okiro E, Muturi D, Newton CR, Fegan G, Marsh K, Williams TN: Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood 2010, 115:215-220.
  • [22]Snow B, Marsh K: How useful are verbal autopsies to estimate childhood causes of death. Health Policy Planning 1992, 7:22-29.
  • [23]Snow RW, Armstrong JR, Forster D, Winstanley MT, Marsh VM, Newton CR, Waruiru C, Mwangi I, Winstanley PA, Marsh K: Childhood deaths in Africa: uses and limitations of verbal autopsies. Lancet 1992, 340:351-355.
  • [24]Mobley CC, Boerma JT, Titus S, Lohrke B, Shangula K, Black RE: Validation study of a verbal autopsy method for causes of childhood mortality in Namibia. J Trop Pediatr 1996, 42:365-369.
  • [25]Quigley MA, Armstrong Schellenberg JR, Snow RW: Algorithms for verbal autopsies: a validation study in Kenyan children. Bull World Health Organ 1996, 74:147-154.
  • [26]Rodriguez L, Reyes H, Tome P, Ridaura C, Flores S, Guiscafre H: Validation of the verbal autopsy method to ascertain acute respiratory infection as cause of death. Indian J Pediatr 1998, 65:579-584.
  • [27]Kahn K, Tollman SM, Garenne M, Gear JS: Validation and application of verbal autopsies in a rural area of South Africa. Trop Med Int Health 2000, 5:824-831.
  • [28]Datta N, Mand M, Kumar V: Validation of causes of infant death in the community by verbal autopsy. Indian J Pediatr 1988, 55:599-604.
  • [29]O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, Snow RW, Newton CR, Marsh K: Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008, 372:1555-1562.
  • [30]Setel PW, Rao C, Hemed Y, Whiting DR, Yang G, Chandramohan D, Alberti KG, Lopez AD: Core verbal autopsy procedures with comparative validation results from two countries. PLoS Med 2006, 3:e268.
  • [31]Murray CJ, Lopez AD, Black R, Ahuja R, Ali SM, Baqui A, Dandona L, Dantzer E, Das V, Dhingra U, Dutta A, Fawzi W, Flaxman AD, Gómez S, Hernández B, Joshi R, Kalter H, Kumar A, Kumar V, Lozano R, Lucero M, Mehta S, Neal B, Ohno SL, Prasad R, Praveen D, Premji Z, Ramírez-Villalobos D, Remolador H, Riley I, et al.: Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr 2011, 9:27. BioMed Central Full Text
  • [32]Christianson AL, Howson CP, Modell B: March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. White Plains, New York: March of Dimes Birth Defects Foundation; 2006.
  • [33]Leitao J, Chandramohan D, Byass P, Jakob R, Bundhamcharoen K, Choprapawon C, de Savigny D, Fottrell E, Franca E, Froen F, Gewaifel G, Hodgson A, Hounton S, Kahn K, Krishnan A, Kumar V, Masanja H, Nichols E, Notzon F, Rasooly MH, Sankoh O, Spiegel P, AbouZahr C, Amexo M, Kebede D, Alley WS, Marinho F, Ali M, Loyola E, Chikersal J, et al.: Revising the WHO Verbal Autopsy instrument to facilitate routine cause-of-death monitoring. Global Health Action 2013, 6:21518.
  • [34]Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez M-G, Baxter A, Bell ML, Benjamin EJ, et al.: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
  文献评价指标  
  下载次数:24次 浏览次数:40次